We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Device-specific guidance for manufacturers on reporting adverse incidents under the vigilance system.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2021.
Expansion of extra-jurisdictional inspection outcomes.
A set of principles for understanding the impact of new variants on antiviral drugs and monoclonal antibodies
For manufacturers reporting adverse incidents with joint replacement implants under the vigilance system.
Report on how community pharmacies can improve the prevention, early detection and management of blood pressure.
Information on medical facilities available in Timor-Leste.
Outlines the level of payment due from members of the Pharmaceutical Price Regulation Scheme (PPRS) in 2018.
For manufacturers reporting adverse incidents with intraocular lenses under the vigilance system.
A document for patients explaining how the highest risk patient groups eligible for new coronavirus treatments will be identified.
Information on the measures in the Health Service Medical Supplies (Costs) Bill.
Information for healthcare professionals, patients, and the public.
This guidance sets out the clinical requirements based on the consensus of what is ‘minimally acceptable’ performance in the opinion of the anaesthesia and intensive care medicine professionals and medical device regulators.
Guidance and change control form to request a change to an Advisory Committee on Borderline Substances (ACBS) application form and/or guidance.
How to move medicines safely by air, following good distribution practice (GDP).
Patient communication about a very low risk to patient safety in response to the field safety notice (FSN) issued by Diffuplast and MHRA.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2023.
How to report adverse incidents involving insulin infusion pumps and integrated meter systems under the vigilance system.
UK businesses can apply for a share of up to £8 million from the Industrial Strategy Challenge Fund for capital projects to improve medicines manufacturing.
Data submission requirements for acute, community and private microbiology services submitting data on all LA/NHS chlamydia tests done in England.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).